Rafael
Martínez Monge
Catedrático de Universidad
José Javier
Aristu Mendioroz
Consultor Médico
Publicaciones en las que colabora con José Javier Aristu Mendioroz (41)
2023
-
Intraoperative Radiotherapy in Lung Cancer: Methodology (Electrons or Brachytherapy), Clinical Experiences, and Long-Term Institutional Results
Medical Radiology (Springer Science and Business Media Deutschland GmbH), pp. 605-621
2021
-
Intraoperative electron beam radiotherapy and perioperative high-dose-rate brachytherapy in previously irradiated oligorecurrent gynecological cancer: clinical outcome analysis
Clinical and Translational Oncology, Vol. 23, Núm. 9, pp. 1934-1941
2019
2016
-
Dose escalation with external beam radiation therapy and high-dose-rate brachytherapy combined with long-term androgen deprivation therapy in high and very high risk prostate cancer: Comparison of two consecutive high-dose-rate schemes
Brachytherapy, Vol. 15, Núm. 2, pp. 127-135
-
Multicatheter breast implant during breast conservative surgery: Novel approach to deliver accelerated partial breast irradiation
Brachytherapy, Vol. 15, Núm. 4, pp. 485-494
2015
-
Salvage surgery and radiotherapy including intraoperative electron radiotherapy in isolated locally recurrent tumors: Predictors of outcome
Radiotherapy and Oncology, Vol. 116, Núm. 2, pp. 316-322
-
Salvage wide resection with intraoperative electron beam therapy or HDR brachytherapy in the management of isolated local recurrences of soft tissue sarcomas of the extremities and the superficial trunk
Brachytherapy, Vol. 14, Núm. 1, pp. 62-70
2013
-
Intraoperative EBRT and resection for renal cell carcinoma: Twenty-year outcomes
Strahlentherapie und Onkologie, Vol. 189, Núm. 2, pp. 129-136
2012
-
Comparison of limited-volume perioperative high-dose-rate brachytherapy and wide-field external irradiation in resected head and neck cancer
Head and Neck, Vol. 34, Núm. 8, pp. 1081-1088
-
External-beam radiation therapy and high-dose rate brachytherapy combined with long-term androgen deprivation therapy in high and very high prostate cancer: Preliminary data on clinical outcome
International Journal of Radiation Oncology Biology Physics, Vol. 82, Núm. 3
-
Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: A validation phase II trial
International Journal of Radiation Oncology Biology Physics, Vol. 83, Núm. 2, pp. 587-593
2011
-
Patterns of response after preoperative intensity-modulated radiation therapy and capecitabine/oxaliplatin in rectal cancer: Is there still a place for ecoendoscopic ultrasound?
International Journal of Radiation Oncology Biology Physics, Vol. 81, Núm. 2, pp. 439-444
-
Patterns of response after preoperative treatment in gastric cancer
International Journal of Radiation Oncology Biology Physics, Vol. 80, Núm. 3, pp. 698-704
-
Use of customized-mold brachytherapy in the management of malignancies arising in the maxillary antrum after maxillectomy: A dosimetric analysis
Brachytherapy, Vol. 10, Núm. 2, pp. 159-162
2010
-
A phase II trial of less than 7 weeks of concomitant cisplatin-paclitaxel chemoradiation in locally advanced cervical cancer
International Journal of Gynecological Cancer, Vol. 20, Núm. 1, pp. 133-140
-
Concomitant cisplatin, paclitaxel, and hyperfractionated radiotherapy in locally advanced head and neck cancer: Comparison of two different schedules
American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 33, Núm. 2, pp. 137-143
-
Intensity-modulated radiation therapy (IMRT) vs. 3D conformal radiotherapy (3DCRT) in locally advanced rectal cancer (LARC): Dosimetric comparison and clinical implications
Radiation Oncology, Vol. 5, Núm. 1
-
Phase II Trial of Radiation Dose Escalation With Conformal External Beam Radiotherapy and High-Dose-Rate Brachytherapy Combined With Long-Term Androgen Suppression in Unfavorable Prostate Cancer: Feasibility Report
International Journal of Radiation Oncology Biology Physics, Vol. 76, Núm. 2, pp. 386-392
-
Sequential administration of dose-dense epirubicin/cyclophosphamide followed by docetaxel/capecitabine for patients with HER2-negative and locally advanced or node-positive breast cancer
Cancer Chemotherapy and Pharmacology, Vol. 65, Núm. 3, pp. 457-465
2009
-
Phase I-II trial of perioperative high-dose-rate brachytherapy in oral cavity and oropharyngeal cancer
Brachytherapy, Vol. 8, Núm. 1, pp. 26-33